Home › Funds › Point72 Asset Management › PCVX
Point72 Asset Management position in PCVX
VAXCYTE INC · Health Care
Latest position (Q1 2026)620.40K sh
Reported value held$36.05M
Portfolio Weight0.05%
First reportedQ3 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 422.80K | $10.15M | New |
| Q4 2022 | 302.60K | $14.51M | Reduce |
| Q1 2023 | 501.10K | $18.78M | Add |
| Q2 2023 | 198.40K | $9.91M | Reduce |
| Q3 2023 | 651.18K | $33.20M | Add |
| Q4 2023 | 30.16K | $1.89M | Reduce |
| Q3 2024 | 359.80K | $41.11M | New |
| Q4 2024 | 251.06K | $20.55M | Reduce |
| Q1 2025 | 245.32K | $9.26M | Reduce |
| Q3 2025 | 696.84K | $25.10M | New |
| Q4 2025 | 161.61K | $7.46M | Reduce |
| Q1 2026 | 620.40K | $36.05M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026